ProFound Therapeutics
A Flagship Pioneering spin-out researching the human proteome and using these insights to unlock new medicines.
The company’s ProFoundry Platform uses state-of-the-art protein detection technologies to systematically identify and validate proteins and dissect their therapeutic potential. The result is an ever-expanding database of tens of thousands of novel proteins, including their connectivity, functionality, and roles in health and disease.
Latest ProFound Therapeutics News & Features
12 June 2024
3 October 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze